Ultrasound-based combination therapy: potential in urologic cancer

References

• Cole WH. Efforts to explain spontaneous regression of cancer. J. Surg. Oncol.17, 201–209 (1981).
   PubMed Web of Science ®Google Scholar
• Smith JA Jr, Herr HW. Spontaneous regression of pulmonary metastases from transitional cell carcinoma. Cancer46, 1499–1502 (1980).
   PubMed Web of Science ®Google Scholar
• Schurmans JR, Blijenberg BG, Mickisch GH, Schröder FH. Spontaneous remission of a bony metastasis in prostatic adenocarcinoma. Urology155, 653 (1996).
   Web of Science ®Google Scholar
• Kim H, Park BK, Kim CK. Spontaneous regression of pulmonary and adrenal metastases following percutaneous radiofrequency ablation of a recurrent renal cell carcinoma. Korean J. Radiol.9, 470– 472 (2008).
   PubMed Web of Science ®Google Scholar
• Lekanidi K, Vlachou PA, Morgan B, Vasanthan S. Spontaneous regression of metastatic renal cell carcinoma: case report. J. Med. Case Reports1, 89 (2007).
   PubMedGoogle Scholar
• Ablin RJ. Cryoimmunotherapy. Br. Med. J.3, 476 (1972).
   PubMed Web of Science ®Google Scholar
• Itoh K, Yamada A. Personalized peptide vaccines: a new therapeutic modality for cancer. Cancer Sci.97, 970–976 (2006).
   PubMed Web of Science ®Google Scholar
• McBride WH, Chiang CS, Olson JL et al. A sense of danger from radiation. Radiat. Res.162, 1–19 (2004).
   PubMed Web of Science ®Google Scholar
• Hu Z, Yang XY, Liu Y et al. Investigation of HIFU-induced anti-tumor immunity in a murine tumor model. J. Transl. Med.5, 1–11 (2007).
   PubMed Web of Science ®Google Scholar
• Liu F, Hu Z, Qiu L et al. Boosting high-intensity focused ultrasound-induced anti-tumor immunity using a sparse-scan strategy that can more effectively promote dendritic cell maturation. J. Transl. Med.27, 2–12 (2010).
   Google Scholar
• Mitragotri S, Kost J. Low-frequency sonophoresis, a review. Adv. Drug Deliv. Rev.56, 589–601 (2004).
   PubMed Web of Science ®Google Scholar
• Juffermans LJ, Kamp O, Dijkmans PA, Visser CA, Musters RJ. Low-intensity ultrasound-exposed microbubbles provoke local hyperpolarization of the cell membrane via activation of BK(Ca) channels. Ultrasound Med. Biol.34, 502–508 (2008).
   PubMed Web of Science ®Google Scholar
• Frenkel V, Kimmel E, Iger Y. Ultrasound-induced intercellular space widening in fish epidermis. Ultrasound Med. Biol.26, 473–480 (2000).
   PubMed Web of Science ®Google Scholar
• Li LY, Yang M, Gao X et al. Prospective comparison of five mediators of the systemic response after high-intensity focused ultrasound and targeted cryoablation for localized prostate cancer. BJU Int.104, 1063–1067 (2009).
   PubMed Web of Science ®Google Scholar
• Matin SF, Sharma P, Gill IS et al. Immunological response to renal cryoablation in an in vivo orthotopic renal cell carcinoma murine model. J. Urol.183, 333–338 (2010).
   PubMed Web of Science ®Google Scholar
• Xu ZL, Zhu XQ, Lu P, Zhou Q, Zhang J, Wu F. Activation of tumor-infiltrating antigen presenting cells by high intensity focused ultrasound ablation of human breast cancer. Ultrasound Med. Biol.35, 50–57 (2008).
   PubMed Web of Science ®Google Scholar
• Kramer G, Steiner GE, Gröbl M et al. Response to sublethal heat treatment of prostatic tumor cells and of prostatic tumor infiltrating T-cells. Prostate58, 109–120 (2004).
   PubMed Web of Science ®Google Scholar
• Melcher A, Todryk S, Hardwick N, Ford M, Jacobson M, Vile RG. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat. Med.4, 581–587 (1998).
   PubMed Web of Science ®Google Scholar
• Hancock HA, Cuesta J et al. Investigations into pulsed high-intensity focused ultrasound-enhanced delivery: preliminary evidence for a novel mechanism. Ultrasound Med. Biol.35, 1722–1736 (2009).
   PubMed Web of Science ®Google Scholar
• Wu F, Zhou L, Chen WR. Host antitumor immune responses to HIFU ablation. Int. J. Hyperthermia23, 165–171 (2007).
   PubMed Web of Science ®Google Scholar
• Van Leenders GJ, Beerlage HP, Ruijter ET et al. Histopathological changes associated with high intensity focused ultrasound (HIFU) treatment for localised adenocarcinoma of the prostate. J. Clin. Pathol.53, 391–394 (2000).
   PubMed Web of Science ®Google Scholar
• Somersan S, Larsson M, Fonteneau JF et al. Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells. J. Immunol.167, 4844–4852 (2001).
   PubMed Web of Science ®Google Scholar
• Mulders P, Tso CL, Gitlitz B et al. Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines. Clin. Cancer Res.5, 445–454 (1999).
   PubMed Web of Science ®Google Scholar
• Steinman RM. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol.9, 271–296 (1991).
   PubMed Web of Science ®Google Scholar
• Satthaporn S, Robins A, Vassanasiri W et al. Dendritic cells are dysfunctional in patients with operable breast cancer. Cancer Immunol. Immunother.53, 510–518 (2004).
   PubMed Web of Science ®Google Scholar
• Higano CS, Schellhammer PF, Small EJ et al. Integrated data from 2 randomized, double-blind, placebo-controlled, Phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer. Cancer115, 3670–3679 (2009).
   PubMed Web of Science ®Google Scholar
• Grabmaier K, Vissers JL, De Weijert MC et al. Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250. Int. J. Cancer85, 865–870 (2000).
   PubMed Web of Science ®Google Scholar
• Mukouyama H, Janezen NK, Hernandez JM et al. Generation of kidney cancer-specific antitumor immune responses using peripheral blood monocytes transduced with a recombinant adenovirus encoding carbonic anhydrase 9. Clin. Cancer Res.10, 1421–1429 (2004).
   PubMed Web of Science ®Google Scholar
• Hernández JM, Bui MH, Han KR et al. Novel kidney cancer immunotherapy based on the granulocyte-macrophage colony-stimulating factor and carbonic anhydrase IX fusion gene. Clin. Cancer Res.9, 1906–1916 (2003).
   PubMed Web of Science ®Google Scholar
• Takahashi A, Kono K, Ichihara F, Sugai H, Fujii H, Matsumoto Y. Vascular endothelial growth factor inhibits maturation of dendritic cells induced by lipopolysaccharide, but not by proinflammatory cytokines. Cancer Immunol. Immunother.53, 543–550 (2004).
   PubMed Web of Science ®Google Scholar
• Almand B, Clark JI, Nikitina E et al. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppresion in cancer. J. Immunol.166, 678–689 (2001).
   PubMed Web of Science ®Google Scholar
• Satthaporn S, Robins A, Vassanasiri W et al. Dendritic cells are dysfunctional in patients with operable breast cancer. Cancer Immunol. Immunother.53, 510–518 (2004).
   PubMed Web of Science ®Google Scholar
• Hu Z, Yang XY, Liu Y et al. Investigation of HIFU-induced anti-tumor immunity in a murine tumor model. J. Transl. Med.5, 34–44 (2007).
   PubMed Web of Science ®Google Scholar
• Hu Z, Yang XY, Liu Y et al. Release of endogenous danger signals from HIFU-treated tumor cells and their stimulatory effects on APCs. Biochem. Biophys. Res. Commun.335, 124–131 (2005).
   PubMed Web of Science ®Google Scholar
• Matzinger P. The danger model: a renewed sense of self. Science296, 301–305 (2002).
   PubMed Web of Science ®Google Scholar
• Liu F, Hu Z, Qiu L et al. Boosting high-intensity focused ultrasound-induced anti-tumor immunity using a sparse-scan strategy that can more effectively promote dendritic cell maturation. J. Transl. Med.8, 1–26 (2010).
   PubMed Web of Science ®Google Scholar
• Tezel A, Paliwal S, Shen Z, Mitragotri S. Low-frequency ultrasound as a transcutaneous immunization adjuvant. Vaccine23, 3800–3807 (2005).
   PubMed Web of Science ®Google Scholar
• Yang R, Reilly CR, Rescorla FJ et al. Effects of high-intensity focused ultrasound in the treatment of experimental neuroblastoma. J. Pediatr. Surg.27, 246–251 (1992).
   PubMed Web of Science ®Google Scholar
• Wu F, Wang ZB, Lu P et al. Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation. Ultrasound Med. Biol.30, 1217–1222 (2004).
   PubMed Web of Science ®Google Scholar
• Tsutsui S, Sonoda K, Sumiyoshi K et al. Prognostic significance of immunological parameters in patients with esophageal cancer. Hepatogastroenterology43, 501–509 (1996).
   PubMedGoogle Scholar
• Cho Y, Miyamoto M, Kato K et al. CD4+ and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma. Cancer Res.63, 1555–1559 (2003).
   PubMed Web of Science ®Google Scholar
• Whiteside T. Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention. Semin. Cancer Biol.16, 3–15 (2006).
   PubMed Web of Science ®Google Scholar
• Finke J, Ferrone S, Frey A, Mufson A, Ochoa A. Where have all the T cells gone? Mechanisms of immune evasion by tumors. Immunol. Today20, 158–160 (1999).
   PubMedGoogle Scholar
• Pardoll D. Does the immune system see tumors as foreign or self? Annu. Rev. Immunol.21, 807–839 (2003).
   PubMed Web of Science ®Google Scholar
• Marincola FM, Jaffee EM, Hicklin DJ, Ferrone S. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv. Immunol.74, 181–273 (2000).
   PubMedGoogle Scholar
• Zhou Q, Zhu X, Zhang J, Xu ZL, Lu P, Wu F. Changes in circulating immunosuppressive cytokine levels of cancer patients after high intensity focused ultrasound treatment. Ultrasound Med. Biol.34, 81–87 (2008).
   PubMed Web of Science ®Google Scholar
• Osada T, Chong G, Tansik R et al. The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients. Cancer Immunol. Immunother.57, 1115–1124 (2008).
   PubMed Web of Science ®Google Scholar
• Khaibullina A, Jang BS, Sun H et al. Pulse high-intensity focused ultrasound enhances uptake of radiolabeled monoclonal antibody to human epidermoid tumor in nude mice. J. Nucl. Med.49, 295–302 (2008).
   PubMed Web of Science ®Google Scholar
• Bednarski MD, Lee JW, Callstrom MR, Li K. in vivo target-specific delivery of macromolecular agents with MR-guided focused ultrasound. Radiology204, 263–268 (1997).
   PubMed Web of Science ®Google Scholar
• Poff JA, Allen CT, Traughber B et al. Pulsed high-intensity focused ultrasound enhances apoptosis and growth inhibition of squamous cell carcinoma xenografts with proteasome inhibitor bortezomib. Radiology248, 485–491 (2008).
   PubMed Web of Science ®Google Scholar
• Frenkel V, Etherington A, Greene M et al. Delivery of liposomal doxorubicin (Doxil) in a breast cancer tumor model: investigation of potential enhancement by pulsed-high intensity focused ultrasound exposure. Acad. Radiol.13, 469–479 (2006).
   PubMed Web of Science ®Google Scholar
• Fry FJ, Johnson LK. Tumor irradiation with intense ultrasound. Ultrasound Med. Biol.4, 337–341 (1978).
   PubMedGoogle Scholar
• Miller DL, Dou C. The potential for enhancement of mouse melanoma metastasis by diagnostic and high-amplitude ultrasound. Ultrasound Med. Biol.32, 1097–1101 (2006).
   PubMed Web of Science ®Google Scholar
• Wu F, Wang ZB, Jin CB et al. Circulating tumor cells in patients with solid malignancy treated by high-intensity focused ultrasound. Ultrasound Med. Biol.30, 511–517 (2004).
   PubMed Web of Science ®Google Scholar
• Bataille N, Vallancien D, Chopin D. Antitumoral local effect and metastatic risk of focused extracorporeal pyrotherapy on Dunning R-3327 tumors. Eur. Urol.29, 72–77 (1996).
   PubMed Web of Science ®Google Scholar
• Oosterhof GO, Cornel EB, Smits GA, Debruyne FM, Schalken JA. Influence of high-intensity focused ultrasound on the development of metastases. Eur. Urol.32, 91–95 (1997).
   PubMed Web of Science ®Google Scholar
• Hancock H, Dreher MR, Crawford N et al. Evaluation of pulsed high intensity focused ultrasound exposures on metastasis in a murine model. Clin. Exp. Metastasis26, 729–738 (2009).
   PubMed Web of Science ®Google Scholar
• Hueman MT, Dehqanzada ZA, Novak TE et al. Phase I clinical trial of a HER-2/neu peptide (E75) vaccine for the prevention of prostate-specific antigen recurrence in high-risk prostate cancer patients. Clin. Cancer Res.11, 7470–7479 (2005).
   PubMed Web of Science ®Google Scholar
• Kouiavskaia DV, Berard CA, Datena E et al. Vaccination with agonist peptide PSA: 154–163 (155L) derived from prostate specific antigen induced CD8 T-cell response to the native peptide PSA: 154–163 but failed to induce the reactivity against tumor targets expressing PSA: a Phase 2 study in patients with recurrent prostate cancer. J. Immunother.32, 655–666 (2009).
   PubMed Web of Science ®Google Scholar
• Lubaroff DM, Reynolds CW, Canfield L et al. Immunologic aspects of the prostate. Prostate2, 233–248 (1981).
   PubMed Web of Science ®Google Scholar
• den Brok MH, Sutmuller RP, Nierkens S et al. Synergy between in situ cryoablation and TLR9 stimulation results in a highly effective in vivo dendritic cell vaccine. Cancer Res.66, 7285–7292 (2006).
   PubMed Web of Science ®Google Scholar